Fingerprint
Dive into the research topics where Felix Lieven D Vervenne is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 1 Article
-
Real-world evaluation of ipilimumab (Ipi)/nivolumab (Nivo) in combination with two cycles of chemotherapy in patients (pts) with programmed death-ligand (PD-L1) negative advanced non-small cell lung cancer (aNSCLC): Interim results of the RW-9LA study
Decoster, L., Vande Kerckhove, S., Ravoet, E. G. F., Vervenne, F. L. D. & Vekens, K., Mar 2025, In: Journal of Thoracic Oncology. 20, 3, 1 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure)